Effect of pegbovigrastim on clinical mastitis and uterine disease during a full lactation in grazing dairy cows.
In this randomized controlled trial on four commercial grazing dairy farms, we investigated whether pegbovigrastim (PEG) treatment affects clinical mastitis (CM) and uterine disease (i.e. retained placenta (RP), metritis and endometritis) occurrence during a full lactation. The association of prepar...
Main Authors: | Joaquín Barca, Ana Meikle, Mette Bouman, Giovanni Gnemmi, Rodrigo Ruiz, Ynte H Schukken |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0252418 |
Similar Items
-
Increase in white blood cell counts by pegbovigrastim in primiparous and multiparous grazing dairy cows and the interaction with prepartum body condition score and non-esterified fatty acids concentration.
by: Joaquín Barca, et al.
Published: (2021-01-01) -
Effect of Pegbovigrastim on Hematological Profile of Simmental Dairy Cows during the Transition Period
by: Francesca Trimboli, et al.
Published: (2019-10-01) -
Grazing and Feeding Management of Lactating Dairy Cows
by: Soriano, Felix Diego
Published: (2014) -
Application of Biochip on Classification of Mastitis Pathogen in Dairy Cows and Effects of Chinese Herbal Medicine on Mastitis and Uterine Involution in Postpartal Dairy Cows
by: Kuo-Hua Lee, et al.
Published: (2013) -
Mathematical and Molecular Epidemiology of Subclinical Mastitis Treatment in Lactating Dairy Cows
by: Barlow, John
Published: (2009)